Filing Details

Accession Number:
0001438133-20-000121
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-04 20:07:39
Reporting Period:
2020-08-03
Accepted Time:
2020-08-04 20:07:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM Surgical & Medical Instruments & Apparatus (3841) 204327508
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542377 B Brian Hansen 11075 Roselle St
San Diego CA 92121
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-03 7,880 $23.00 12,545 No 4 M Direct
Common Stock Disposition 2020-08-03 7,880 $105.16 4,665 No 4 S Direct
Common Stock Acquisiton 2020-08-03 3,400 $23.00 8,065 No 4 M Direct
Common Stock Disposition 2020-08-03 3,400 $105.99 4,665 No 4 S Direct
Common Stock Acquisiton 2020-08-03 4,354 $69.50 9,019 No 4 M Direct
Common Stock Disposition 2020-08-03 4,354 $106.55 4,665 No 4 S Direct
Common Stock Acquisiton 2020-08-03 8,320 $9.00 12,985 No 4 M Direct
Common Stock Disposition 2020-08-03 8,320 $106.11 4,665 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2020-08-03 11,280 $0.00 11,280 $23.00
Common Stock Stock Option Disposition 2020-08-03 4,354 $0.00 4,354 $69.50
Common Stock Stock Option Disposition 2020-08-03 8,320 $0.00 8,320 $9.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
9,146 No 4 M Direct
2,180 No 4 M Direct
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $104.84 and $105.83.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  3. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $105.84 and $106.26. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  4. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.51 and $106.65. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  5. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.00 and $106.50. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  6. The option vested as to fifty percent (50%) of the underlying shares on 12/16/2017, and the remaining shares vested in twelve (12) equal monthly installments thereafter.
  7. The expiration date for these options is 10 years from the date of grant.
  8. The option vested as to twenty-five percent (25%) of the underlying shares on 02/16/2017, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.
  9. The option vested as to twenty-five percent (25%) of the underlying shares on 05/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.